試す 金 - 無料
NATHEALTH Foundation inducts Dr Indu Bhushan & Neeraj Jain to the board
Bio Spectrum
|BioSpectrum India Jan 2025
NATHEALTH Foundation has announced the induction of two distinguished leaders, Dr Indu Bhushan and Neeraj Jain, to its Board.
-
Their unparalleled expertise and commitment to advancing healthcare will significantly strengthen the Foundation's mission to foster a robust and inclusive healthcare ecosystem in India. Dr Indu Bhushan, Former IAS officer, Senior Associate at Bloomberg School of Public Health and Johns Hopkins University and Founding CEO of the National Health Authority, has a distinguished career spanning over four decades. As the CEO of Ayushma
このストーリーは、Bio Spectrum の BioSpectrum India Jan 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、9,500 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Bio Spectrum からのその他のストーリー
Bio Spectrum
Navigating the Complexities of Pharma Packaging Sustainability
Pharma companies in India are increasingly adopting sustainable methods in packaging to ensure that medicines remain safe and the environment is protected. Various initiatives by the government, focusing on reducing carbon footprints, are revolutionising the pharma packaging industry.
8 mins
September 2025
Bio Spectrum
Are BioStartUps in a Funding/Innovation Rut?
At the BioStartUps Founders & Investors Forum 2025, held on August 1, 2025 at the CIDCO Exhibition Centre in Vashi, Navi Mumbai, biotech industry stalwarts deliberated on the country's innovation and startup ecosystem.
10 mins
September 2025
Bio Spectrum
How Do Recent Deaths Impact Gene Therapy Development?
Cell and gene therapy (CGT) is among the most closely watched areas in pharma and biotech.
4 mins
September 2025
Bio Spectrum
HealthQuad appoints Namit Chugh as Director
Quadria Group, Asia's leading healthcare-focused private equity platform, has announced the appointment of Namit Chugh as Director at HealthQuad, India's leading healthcare-focused growth venture capital platform.
1 min
September 2025
Bio Spectrum
Why Is Endoscopy Crucial for Gl Cancer Diagnosis?
The increased demand for gastrointestinal (GI) diagnostics in India, driven by rising disease rates and awareness of early intervention, is not evenly distributed. While major urban hospitals have expanded their endoscopic capabilities, many semi-urban and rural areas face limited access. Addressing this disparity is crucial for extending the benefits of early disease detection across the country.
4 mins
September 2025
Bio Spectrum
New England Biolabs launches NEBNext low-bias small RNA library prep kit
US-based New England Biolabs (NEB) has announced the launch of the NEBNext Low-bias Small RNA Library Prep Kit, designed to minimise biased representation of small RNA species in sequencing data.
1 min
September 2025
Bio Spectrum
Qiagen expands NGS portfolio with launch of QIAseq XHYB long read panels
Qiagen has announced the launch of its new QIAseq xHYB Long Read Panels, a suite of target enrichment solutions designed to unlock long-read sequencing of genomically complex regions.
1 min
September 2025
Bio Spectrum
"Awareness and consistent training are needed with the growing demand for effective skin treatments in India"
India’s dermatology and aesthetic market is reportedly among the fastest-growing globally, projected to grow at a CAGR of 10.11 per cent from 2025 to 2032.
4 mins
September 2025
Bio Spectrum
Dr. Moopen's Legacy Scholarship & Fellowships to aid 25 students from across India
In a path breaking initiative to make medical education accessible to meritorious students and students from economically challenged backgrounds, Padma Shri Dr Azad Moopen, Founder & Chairman of Aster DM Healthcare and a globally recognised philanthropist, has announced an annual scholarship programme Dr. Moopen's Legacy Scholarship & Fellowships Programme aimed at supporting meritorious students seeking admissions in Dr. Moopen's Medical College, Dr Moopen's Nursing College and Dr Moopen's College of Pharmacy in Wayanad, Kerala.
1 min
September 2025
Bio Spectrum
Iberia Pharma set to open manufacturing unit in India with investment of Rs 70 Cr
Gurugram-based Iberia Pharmaceuticals has announced its new hi-tech manufacturing and research facility spread across 60,000 sq. ft. in Jhajjar, Haryana.
1 min
September 2025
Listen
Translate
Change font size